| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Decision Analysis Model Predicts the Optimal Treatment Pathway for Patients with Colorectal Cancer and Resectable Synchronous Liver Metastases
|
Aloia, Thomas A.
|
|
2008
|
7 |
3 |
p. 197-201
5 p.
|
article
|
| 2 |
Adherence to Surveillance Guidelines After Curative Resection for Stage II/III Colorectal Cancer
|
Cheung, Winson Y.
|
|
2008
|
7 |
3 |
p. 191-196
6 p.
|
article
|
| 3 |
Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone
|
Freeman, Daniel J.
|
|
2008
|
7 |
3 |
p. 184-190
7 p.
|
article
|
| 4 |
Biomarker Validation: In Situ Analysis of Protein Expression Using Semiquantitative Immunohistochemistry-Based Techniques
|
Sullivan, Catherine A.W.
|
|
2008
|
7 |
3 |
p. 172-177
6 p.
|
article
|
| 5 |
Colon Cancer: Update on Adjuvant Therapy
|
Mano, Max S.
|
|
2008
|
7 |
3 |
p. 178-183
6 p.
|
article
|
| 6 |
Highlights from: The 2008 American Society of Clinical Oncology Gastrointestinal Cancers Symposium; Orlando, FL; January 25-27, 2008
|
Grothey, Erin
|
|
2008
|
7 |
3 |
p. 165-171
7 p.
|
article
|
| 7 |
Intussusception in Colorectal Cancer
|
Chand, Manish
|
|
2008
|
7 |
3 |
p. 204-205
2 p.
|
article
|
| 8 |
Is XELOX Equivalent to FOLFOX or Other Continuous-Infusion 5-Fluorouracil Chemotherapy in Metastatic Colorectal Cancer?
|
Douillard, Jean-Yves
|
|
2008
|
7 |
3 |
p. 206-211
6 p.
|
article
|
| 9 |
Molecular Biomarker Development for Anti-EGFR Therapy: Moving Beyond EGFR Expression
|
Chu, Edward
|
|
2008
|
7 |
3 |
p. 162-
1 p.
|
article
|
| 10 |
Selected Clinical Trials in Colorectal Cancer
|
|
|
2008
|
7 |
3 |
p. 212-
1 p.
|
article
|
| 11 |
Successful Administration of Panitumumab Alone After Severe Infusion Reaction to Cetuximab in a Patient with Metastatic Colorectal Cancer
|
Cartwright, Thomas H.
|
|
2008
|
7 |
3 |
p. 202-203
2 p.
|
article
|
Journal description